Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jul-Aug;21(4):260-1.
doi: 10.4103/1319-3767.161633.

Ribavirin-free treatment may soon be a reality

Bandar Al-Judaibi  1
Affiliations
Comment

Ribavirin-free treatment may soon be a reality

Bandar Al-Judaibi. Saudi J Gastroenterol. 2015 Jul-Aug.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Alghamdi AA, Alqutub A, Abaalkhail F, Sanai FM, Alghamdi H, Altraif I, et al. SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection. Saudi J Gastroenterol. 2015;21:60–3. - PMC - PubMed
    1. Afdhal N, Reddy KR, Nelson DR, Lawitz E, Gordon SC, Schiff E, et al. ION-2 Investigators. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med. 2014;370:1483–93. - PubMed
    1. Bourlière M, Bronowicki JP, de Ledinghen V, Hézode C, Zoulim F, Mathurin P, et al. Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: A randomised, double-blind, phase 2 trial (SIRIUS) Lancet Infect Dis. 2015;15:397–404. - PubMed
    1. Lawitz E, Sulkowski MS, Ghalib R, Rodriguez-Torres M, Younossi ZM, Corregidor A, et al. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: The COSMOS randomised study. Lancet. 2014;384:1756–65. - PubMed
    1. Doss W, Shiha G, Hassany M, Soliman R, Fouad R, Khairy M, et al. Sofosbuvir Plus ribavirin for treating Egyptian patients with hepatitis C genotype 4. J Hepatol. 2015 Epub ahead of print. - PubMed